NEW YORK, Sept. 30, 2024 — The Gross Law Firm is notifying shareholders of Sage Therapeutics, Inc. (NASDAQ: SAGE).
Shareholders who purchased SAGE shares during the specified period are encouraged to contact the firm regarding possible lead plaintiff appointment. Being appointed as lead plaintiff isn’t necessary to benefit from any potential recovery.
CONTACT US HERE:
CLASS PERIOD: April 12, 2021 to July 23, 2024
ALLEGATIONS: The lawsuit claims that during the class period, Defendants made statements that were materially false and/or misleading or failed to disclose that: (i) Zuranolone, a treatment for postpartum depression, was less effective for Major Depressive Disorder (MDD) than defendants had presented to investors; (ii) consequently, the FDA was unlikely to approve Zuranolone for treating MDD in its current form, and Zuranolone’s clinical results for MDD, as well as its overall regulatory and commercial potential, were exaggerated; (iii) SAGE-718 was less effective in treating Mild Cognitive Impairment (MCI) related to Parkinson’s Disease (PD) than defendants had informed investors; (iv) as a result, SAGE-718’s clinical, regulatory, and commercial prospects as a treatment for MCI due to PD were inflated; (v) SAGE-324 was less effective in treating essential tremor than defendants had led investors to believe; (vi) accordingly, SAGE-324’s clinical, regulatory, and commercial prospects as a treatment for essential tremor were overstated; and (vii) due to these factors, the Company’s public statements were materially false and misleading throughout the relevant period.
DEADLINE: October 28, 2024 Shareholders shouldn’t wait to register for this class action. Register your information here:
NEXT STEPS FOR SHAREHOLDERS: After registering as a shareholder who purchased SAGE shares during the timeframe mentioned above, you’ll be enrolled in a portfolio monitoring software to keep you updated on the case’s progress. The deadline to request to be a lead plaintiff is October 28, 2024. There are no costs or obligations associated with participating in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have experienced losses due to deception, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies uphold responsible business practices and demonstrate good corporate citizenship. The firm seeks recovery for investors who incurred losses when false and/or misleading statements or the omission of material information by a company caused an artificial inflation of the company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email:
Phone: (646) 453-8903
SOURCE The Gross Law Firm